Long‐Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population
- 1 August 2001
- journal article
- clinical trial
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 49 (8), 1025-1031
- https://doi.org/10.1046/j.1532-5415.2001.49204.x
Abstract
Click on the article title to read more.Keywords
This publication has 30 references indexed in Scilit:
- Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent InfluenzaNew England Journal of Medicine, 1999
- Clinical Pharmacokinetics of the Prodrug Oseltamivir and its Active Metabolite Ro 64-0802Clinical Pharmacokinetics, 1999
- Influenza Neuraminidase Inhibitors Possessing a Novel Hydrophobic Interaction in the Enzyme Active Site: Design, Synthesis, and Structural Analysis of Carbocyclic Sialic Acid Analogues with Potent Anti-Influenza ActivityJournal of the American Chemical Society, 1997
- Safety and efficacy of long-term use of rimantadine for prophylaxis of type A influenza in nursing homesAntimicrobial Agents and Chemotherapy, 1995
- Nursing Home Outbreak of Influenza A (H3N2): Evaluation of Vaccine Efficacy and Influenza Case DefinitionsInfection Control & Hospital Epidemiology, 1992
- Emergence and Transmission of Influenza A Viruses Resistant to Amantadine and RimantadineCurrent Topics in Microbiology and Immunology, 1992
- Emergence and Apparent Transmission of Rimantadine-Resistant Influenza A Virus in FamiliesNew England Journal of Medicine, 1989
- Structure of the catalytic and antigenic sites in influenza virus neuraminidaseNature, 1983
- A Controlled Trial of Amantadine and Rimantadine in the Prophylaxis of Influenza a InfectionNew England Journal of Medicine, 1982
- BRIEF ASSESSMENT OF THE MENTAL STATE IN GERIATRIC DOMICILIARY PRACTICE. THE USEFULNESS OF THE MENTAL STATUS QUESTIONNAIREAge and Ageing, 1973